BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22751344)

  • 1. Diagnosis and management of parathyroid cancer.
    Schulte KM; Talat N
    Nat Rev Endocrinol; 2012 Oct; 8(10):612-22. PubMed ID: 22751344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid carcinoma.
    Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
    Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
    Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
    Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
    Cetani F; Marcocci C; Torregrossa L; Pardi E
    Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.
    Zhang JH; Seigneur EM; Pandey M; Loshakov A; Dagur PK; Connelly PS; Koo L; Panicker LM; Simonds WF
    Cell Death Dis; 2012 Feb; 3(2):266. PubMed ID: 22297294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
    Guarnieri V; Scillitani A; Muscarella LA; Battista C; Bonfitto N; Bisceglia M; Minisola S; Mascia ML; D'Agruma L; Cole DE
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2827-32. PubMed ID: 16720667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid carcinoma.
    Mittendorf EA; McHenry CR
    J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid cancer.
    Sharretts JM; Kebebew E; Simonds WF
    Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
    Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
    Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
    Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
    Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors.
    Siu WK; Law CY; Lam CW; Mak CM; Wong GW; Ho AY; Ho KY; Loo KT; Chiu SC; Chow LT; Tong SF; Chan AY
    Fam Cancer; 2011 Dec; 10(4):695-9. PubMed ID: 21732217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
    Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
    Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of de novo germline mutations in the HRPT2 gene in two apparently sporadic cases with challenging parathyroid tumor diagnoses.
    Cavaco BM; Santos R; Félix A; Carvalho D; Lopes JM; Domingues R; Sirgado M; Rei N; Fonseca F; Santos JR; Sobrinho L; Leite V
    Endocr Pathol; 2011 Mar; 22(1):44-52. PubMed ID: 21360064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.
    Guarnieri V; Battista C; Muscarella LA; Bisceglia M; de Martino D; Baorda F; Maiello E; D'Agruma L; Chiodini I; Clemente C; Minisola S; Romagnoli E; Corbetta S; Viti R; Eller-Vainicher C; Spada A; Iacobellis M; Malavolta N; Carella M; Canaff L; Hendy GN; Cole DE; Scillitani A
    Cell Oncol (Dordr); 2012 Dec; 35(6):411-22. PubMed ID: 22987117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.